美國居民不適用 XM 服務。
L
L

Lonza


財經新聞

ABB, Klepierre, Ryanair

EUROPE RESEARCH ROUNDUP-ABB, Klepierre, Ryanair June 20 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including ABB, Klepierre and Ryanair, on Thursday. HIGHLIGHTS * ABB Ltd ABBN.S : Citigroup cuts to neutral from buy * ASM International NV ASMI.AS : Morgan Stanley raises to overweight from equal weight * Deutsche Lufthansa AG LHAG.DE : Stifel cuts to hold from buy * Klepierre LOIM.PA : HSBC raises to buy from hold * Ryanair RYA.I : UBS cu
A
A
B
C
D
D
G
K
K
L
L
L
M
N
N
P
S
W
A
A
A
L
R
S

AB Dynamics, Etteplan, Wise

EUROPE RESEARCH ROUNDUP-AB Dynamics, Etteplan, Wise June 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including AB Dynamics, Etteplan and Wise, on Friday. HIGHLIGHTS * AB Dynamics Plc ABDP.L : Berenberg re-initiates coverage With Buy rating; PT 2,620p * Crest Nicholson CRST.L : Barclays cuts target price to 230p from 258p * Etteplan Oyj ETTE.HE : Evli Research raises to buy from hold * Halma HLMA.L : Barclays raises target price to 284
B
C
E
H
H
J
L
O
O
P
R
S
S
T
U
V
V
Z
H
A
R

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Swiss pharma supplier Lonza reports softer Q1 but confirms outlook

UPDATE 1-Swiss pharma supplier Lonza reports softer Q1 but confirms outlook Adds outlook in paragraph 1, info about Biosecure Act in paragraph 5-6, CFO quote in paragraph 7 By Chiara Holzhaeuser and Tristan Veyet May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S reported a "softer Q1" on Tuesday, while confirming its 2024 outlook, saying its lacklustre performance was mainly due to the phasing of commercial batches and a weaker start at its bioscience business.
B
L

Swiss pharma supplier Lonza flags signs of recovery in biotech funding

Swiss pharma supplier Lonza flags signs of recovery in biotech funding May 14 (Reuters) - Swiss pharmaceutical supplier Lonza LONN.S confirmed its 2024 outlook on Tuesday, flagging early signs of recovery in biotech funding even as clinical demand in its biologics division remained soft in the first quarter. It said commercial performance was positive across its biologics, small molecules, and cell & gene businesses in the quarter, while development in its capsules & health ingredients unit was
B
L

Lonza Group Confirms 2024 Outlook

BRIEF-Lonza Group Confirms 2024 Outlook May 14 (Reuters) - LONZA GROUP AG LONN.S : PERFORMANCE IN LINE WITH EXPECTATIONS FOR FULL-YEAR 2024 H2 SALES EXPECTED TO BE SOLID CONFIRMS OUTLOOK 2024 Source text for Eikon: ID:nSN6xhSvm Further company coverage: LONN.S (Gdansk Newsroom)
L

Swiss stocks - Factors to watch on May 14

Swiss stocks - Factors to watch on May 14 ZURICH/BERLIN, May 14 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: UBS UBSG.S UBS CEO Sergio Ermotti warned on Monday that any delay to the integration of its technology and data with those of former rival Credit Suisse would erode planned cost savings, as he vowed to see the process through and stay on until 2027. GLENCORE GLEN.L Australia's Queensland state will decide this month whether to give Glencore a key
A
G
L
S
S
U

Swiss stocks - Factors to watch on May 13

Swiss stocks - Factors to watch on May 13 ZURICH/BERLIN, May 13(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: NESTLE NESN.S Media/Bloomberg - PAI to delay exit from 10 million dollar ice cream joint venture. KL 1 Together with the German aviation firm Lilium 5KD.F , the company will set up new sites in France in a combined investment of 700 million euros.
A
L
N
S
S

Adecco Group, Centrica, UBS

EUROPE RESEARCH ROUNDUP-Adecco Group, Centrica, UBS May 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adecco Group, Centrica and UBS, on Wednesday. HIGHLIGHTS * Adecco Group AG ADEN.S : RBC raises to outperform from sector perform * Centrica CNA.L : UBS raises to buy from neutral * Direct Line Insurance DLGD.L : Morgan Stanley resumes coverage with equal-weight rating * Lindt & Spruengli LISN.S : Barclays raises to equal weight
A
A
A
A
A
A
B
B
B
B
B
C
D
E
G
H
H
I
K
L
L
L
S
S
S
V
A
A
B
B
D
D
M

Swiss stocks - Factors to watch on May 8

Swiss stocks - Factors to watch on May 8 ZURICH/BERLIN, May 8(Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS * Talenthouse THAGN.S - Postponement Of Publication Of The Annual Report 2023 Until 31 May 2024 * EDAG Engineering Group ED4.DE - Harald Keller Appointed CEO As Of July 01, 2024 * Garrett Motion G02.F - Upsizing And Pricing Of Private Offering Of $800 Million Of Senior Notes Due 2032 ANNUAL GENERAL MEETINGS ALCON AG ALCC.S - 0.24
A
K
L
S

Roche to review manufacturing further after sale of site to Lonza, CEO says

Roche to review manufacturing further after sale of site to Lonza, CEO says FRANKFURT, April 24 (Reuters) - Roche ROG.S will further review its manufacturing network after the sale of a major site to Lonza LONN.S last month because biotech production technology has become much more efficient. Speaking after the release of quarterly sales, CEO Thomas Schinecker said the Swiss group has the largest manufacturing capacity in the pharma industry and it needs to adapt because technology upgrades in s
L
R

Swiss stocks - Factors to watch on April 18

Swiss stocks - Factors to watch on April 18 ZURICH/BERLIN, Apr 18(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS AG UBSG.S UBS Group is planning another round of job cuts after its takeover of Credit Suisse that is expected to affect over a hundred positions across the group's global investment bank, Bloomberg News reported on Wednesday.
A
L
N
S
U

Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon

BRIEF-Lonza Prices EUR 1 Bln Straight Bond With 3.875% Coupon April 17 (Reuters) - Lonza Group AG LONN.S : LONZA PRICES EUR 1 BILLION STRAIGHT BOND WITH A 3.875% COUPON BOND HAS A MATURITY OF 12 YEARS AND AN ANNUAL COUPON OF 3.875% Source text for Eikon: ID:nEQ4MCSfYa Further company coverage: LONN.S
L

Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion

UPDATE 1-Fujifilm to invest $1.2 bln in North Carolina plant in biopharma expansion Adds Nikkei report on overall biopharma investment plan, paragraphs 3-4 TOKYO, April 12 (Reuters) - Japan's Fujifilm 4901.T will invest $1.2 billion to expand its North Carolina plant as part of its plans to expand biopharmaceutical contract manufacturing businesses in the United States and Europe, the company said on Thursday.
L

Biotech Firm NeuroSense Collaborates With Lonza To Identify Exosome-based Biomarkers

BRIEF-Biotech Firm NeuroSense Collaborates With Lonza To Identify Exosome-based Biomarkers April 9 (Reuters) - Lonza and NeuroSense Therapeutics: NEUROSENSE THERAPEUTICS: COLLABORATION WITH LONZA TO EVALUATE BIOLOGICAL CHANGES OCCURRING IN PEOPLE WITH NEURODEGENERATIVE DISEASES, INCLUDING ALS Source text for Eikon: ID:nPn1rPMXFa
L

Essilorluxottica, Remy Cointreau, Scout24

EUROPE RESEARCH ROUNDUP-Essilorluxottica, Remy Cointreau, Scout24 April 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Essilorluxottica, Remy Cointreau and Scout24, on Tuesday. HIGHLIGHTS * Burberry BRBY.L : Bernstein cuts target price to 1384p from 1402p * Essilorluxottica SA ESLX.PA : HSBC cuts to hold from buy * Remy Cointreau RCOP.PA : Jefferies cuts target price to EUR 120 from EUR 130 * Renault RENA.PA : Barclays raises to
A
A
B
B
B
C
H
I
K
K
K
L
L
L
M
N
O
P
R
R
S
S
S
T
T
T
U
V
A
A
J
J
M

Swiss stocks - Factors to watch on April 9

Swiss stocks - Factors to watch on April 9 ZURICH/BERLIN, April 9 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: SWISS NATIONAL BANK SNBN.S The Swiss National Bank sees no need for a central bank digital currency (CBDC) to be issued to the general public, Chairman Thomas Jordan said on Monday. The bank's vice chairman is set to speak on interest rates, foreign exchange interventions and achieving price stability on Tuesday.
B
C
L
U

Air France, Deutsche Bank, FinecoBank

EUROPE RESEARCH ROUNDUP-Air France, Deutsche Bank, FinecoBank April 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air France, Deutsche Bank and FinecoBank, on Wednesday. HIGHLIGHTS * Air France-KLM AIRF.PA : JP Morgan cuts target price to EUR 9 from EUR 9.20 * Deutsche Bank AG DBKGn.DE : JP Morgan raises PT to EUR 15.20 from EUR 15 * FinecoBank FBK.MI : JP Morgan raises to overweight from neutral * Segro SGRO.L : Barclays raise
B
B
D
D
H
H
I
J
J
L
N
P
R
S
V
A
F

Europe set for mixed start

LIVE MARKETS-Europe set for mixed start Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com EUROPE SET FOR MIXED START European shares were set for a mixed start on Wednesday, as traders assessed chances of fewer Fed rate cuts this year following strong data in the U.S.
L
R
R
S
S
F
I
S
U
G



細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明